Plus (PSTV) delivered earnings and revenue surprises of +88.89% and -18.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues...
Vous n'êtes pas connecté
Rubriques :
- ZACKS.COM - All Stories - 14/Aug 21:30
Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates
Plus (PSTV) delivered earnings and revenue surprises of +88.89% and -18.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Articles similaires
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - 11/Aug 22:55
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of +22.22% and -9.62%, respectively, for the quarter ended June 2025. Do the...
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates
zacks.com - 11/Aug 22:55
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of +69.37% and +20.84%, respectively, for the quarter ended June 2025. Do the...
Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - 11/Aug 23:00
Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of -13.68% and -5.37%, respectively, for the quarter ended June 2025. Do the...
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates
zacks.com - 12/Aug 19:00
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers...
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates
zacks.com - 12/Aug 19:00
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers...
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - 12/Aug 19:00
BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the...
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - 12/Aug 19:00
BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of -6.52% and -52.00%, respectively, for the quarter ended June 2025. Do the...
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates
zacks.com - 12/Aug 19:00
TScan Therapeutics (TCRX) delivered earnings and revenue surprises of 0.00% and +58.07%, respectively, for the quarter ended June 2025. Do the numbers...
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Beats Revenue Estimates
zacks.com - 12/Aug 19:00
TScan Therapeutics (TCRX) delivered earnings and revenue surprises of 0.00% and +58.07%, respectively, for the quarter ended June 2025. Do the numbers...
Les derniers communiqués
-
NASA's Webb telescope discovers new moon orbiting Uranus
National Aeronautics and Space Administration - 22/08/2025
-
InventHelp Inventor Develops New Winter Hose Accessory (SGM-543)
Inventhelp - 22/08/2025
-
Netskope Files Registration Statement for Proposed Initial Public Offering
Netskope - 22/08/2025
-
Anesthesia and Respiratory Devices Market to Hit $74.8 Billion by 2030
BCC Research - 22/08/2025
-
RDDT Investors Have Opportunity to Lead Reddit, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Schall Law Firm - 18/08/2025
-
90% of Games Developers Already Using AI in Workflows, According to New Google Cloud Research
GOOGLE - 18/08/2025
-
Zerova Partners with Yunex Traffic to Strengthen After-Sales Support in the UK
Zerova - 18/08/2025
-
UFC 319: Chimaev wins middleweight championship
UFC - 18/08/2025
-
Siemba Named a Sample Vendor in Three 2025 Gartner® Hype Cycle™ Reports for the Second Year in a Row
Siemba - 16/08/2025
-
Faruqi & Faruqi Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 – CAPR
Faruqi & Faruqi, LLP - 15/08/2025